gabexate has been researched along with Becker Muscular Dystrophy in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Excerpt | Relevance | Reference |
---|---|---|
"Duchenne muscular dystrophy is known to be caused by a defective gene of dystrophin, a 427-kDa cytoskeletal protein, but the effective therapeutic drug is presently unavailable." | 1.32 | Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice. ( Ban, S; Kakefuda, R; Kikukawa, Y; Nagahiro, K; Sawada, H; Shiomi, T; Yokosawa, H, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sawada, H | 1 |
Nagahiro, K | 1 |
Kikukawa, Y | 1 |
Ban, S | 1 |
Kakefuda, R | 1 |
Shiomi, T | 1 |
Yokosawa, H | 1 |
1 other study available for gabexate and Becker Muscular Dystrophy
Article | Year |
---|---|
Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice.
Topics: Animals; Esters; Gabexate; Guanidines; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; | 2003 |